A 58-year-old cirrhotic man with ascites undergoes large volume paracentesis (6 liters removed). Four hours later, he becomes hypotensive (BP 80/50 mmHg) and tachycardic (HR 115/min). Labs show: Cr 2.1 mg/dL (baseline 1.0), Na+ 128 mEq/L, Hct 38%. What is the most appropriate immediate management?
A 42-year-old woman with prolonged vomiting from gastroparesis is admitted with weakness. Labs show: K+ 2.1 mEq/L, pH 7.51, HCO3- 42 mEq/L, Mg2+ 1.4 mg/dL. She receives 80 mEq of IV potassium chloride over 24 hours, but repeat K+ is 2.3 mEq/L. What explains the refractory hypokalemia?
A 65-year-old diabetic man with TURP syndrome presents with confusion, nausea, and seizures 2 hours post-operatively. Labs show: Na+ 115 mEq/L, serum osmolality 240 mOsm/kg. He weighs 70 kg. What is the target sodium correction rate and fluid management strategy?
A 50-year-old man is 5 days post-operative from a Whipple procedure. He has had high nasogastric output (1500 mL/day) and has been NPO. Labs show: Na+ 132 mEq/L, K+ 2.9 mEq/L, Cl- 88 mEq/L, HCO3- 38 mEq/L, pH 7.52. Urine chloride is 8 mEq/L. What is the appropriate management?
A 28-year-old trauma patient received 8 units of packed RBCs, 6 units of FFP, and 2 units of platelets during damage control surgery. Two hours post-op, he develops: peaked T waves on EKG, K+ 6.8 mEq/L, Ca2+ 7.2 mg/dL, ionized calcium 0.9 mmol/L, pH 7.25. Which metabolic derangement is most responsible for his cardiac instability?
A 38-year-old woman develops severe diarrhea after small bowel resection for Crohn's disease. Over 3 days, she has lost 6 kg. Labs show: Na+ 148 mEq/L, K+ 2.8 mEq/L, Cl- 118 mEq/L, HCO3- 15 mEq/L, BUN 45 mg/dL, Cr 1.8 mg/dL (baseline 0.9). Urine sodium is 8 mEq/L. What fluid should be administered?
A 70-year-old man with small bowel obstruction has been receiving aggressive IV fluid resuscitation with normal saline for 48 hours (total 12 liters). His nasogastric tube has drained 3 liters. Labs show: Na+ 138 mEq/L, K+ 3.2 mEq/L, Cl- 112 mEq/L, HCO3- 18 mEq/L, pH 7.30. What acid-base disturbance is present?
A 55-year-old man with a history of alcoholism presents with acute pancreatitis. His calcium level is 6.8 mg/dL, albumin is 2.5 g/dL, and he is symptomatic with perioral numbness and carpopedal spasm. After correcting for albumin, his corrected calcium is 7.6 mg/dL. What is the most appropriate initial treatment?
A 62-year-old woman develops postoperative hyponatremia (sodium 118 mEq/L) on day 2 after a total colectomy. She is confused and lethargic. Her urine sodium is 45 mEq/L, urine osmolality is 520 mOsm/kg, and serum osmolality is 245 mOsm/kg. She has been receiving D5W at 125 mL/hr. What is the most likely cause of her hyponatremia?
A 45-year-old man undergoes emergent exploratory laparotomy for a gunshot wound to the abdomen. Intraoperatively, 2 liters of blood are lost. His blood pressure is 85/50 mmHg, heart rate is 125/min, and urine output is 15 mL/hr. The anesthesiologist has administered 3 liters of lactated Ringer's solution. What is the most appropriate next step in fluid resuscitation?
Explanation: ***5% albumin 6-8 grams per liter of ascites removed*** - This patient is experiencing **post-paracentesis circulatory dysfunction (PPCD)**, characterized by hypotension and **acute kidney injury** (doubled creatinine) following a large volume paracentesis (>5L). - Administration of **intravenous albumin** is the gold standard treatement to expand the **effective arterial blood volume** and prevent further deterioration into hepatorenal syndrome. *Normal saline bolus 2 liters* - In cirrhotic patients, **crystalloids** are less effective as they rapidly redistribute into the **interstitial space** (third-spacing) and can worsen ascites/edema. - Saline does not provide the **oncotic pressure** required to counteract the splanchnic vasodilation typical of PPCD. *Octreotide and midodrine for hepatorenal syndrome* - While these agents are used for **Hepatorenal Syndrome (HRS)**, the immediate priority in post-procedure hypotension is **volume expansion** to correct the circulatory dysfunction. - These medications are typically reserved for patients who do not respond to **volume expansion with albumin** or meet specific criteria for type 1 HRS. *Vasopressors to maintain blood pressure* - Vasopressors like **norepinephrine** are generally considered after fluid resuscitation with **albumin** has failed to restore hemodynamic stability. - Using pressors alone ignores the underlying **intravascular volume deficit** caused by the fluid shift after paracentesis. *Re-infusion of filtered ascitic fluid* - This is not a standard or recommended clinical practice due to risks of **infection**, **coagulopathy**, and lack of evidence for efficacy. - The specific requirement in this pathology is **concentrated albumin** to maintain oncotic pressure, which ascitic fluid does not provide efficiently.
Explanation: ***Hypomagnesemia preventing potassium retention*** - Low **intracellular magnesium** inhibits **ROMK channels** in the renal collecting duct; without magnesium inhibition, these channels allow excessive **potassium secretion** into the urine. - **Magnesium** is also a necessary cofactor for the **Na+/K+-ATPase pump**, which is required to transport potassium into the cells and maintain serum levels. *Secondary hyperaldosteronism from volume depletion* - While **volume depletion** triggers the **Renin-Angiotensin-Aldosterone System (RAAS)**, leading to potassium loss, it does not typically cause absolute refraction to supplementation in the presence of adequate IV fluids. - Addressing the **volume status** alone will not fix the hypokalemia if the **magnesium deficiency** is still driving renal wasting. *Insufficient potassium replacement dose* - A dose of **80 mEq** over 24 hours is a significant amount of supplement for a patient who is hospitalized and being monitored. - Failure to increase serum potassium by more than 0.2 mEq/L despite high-dose IV replacement suggests an **active wasting mechanism** rather than just an under-correction. *Ongoing losses from continued vomiting* - Although vomiting causes loss of **hydrochloric acid** and induces **metabolic alkalosis**, the gastric fluid itself contains relatively low concentrations of potassium. - The primary cause of hypokalemia in vomiting is **renal loss** (due to alkalosis and RAAS) rather than direct loss of potassium from the stomach. *Metabolic alkalosis promoting intracellular potassium shift* - **Alkalosis** causes an intracellular shift of potassium as **hydrogen ions** exit cells to help buffer the serum pH. - While this contributes to the initial low lab value, it does not explain why **exogenous IV potassium** fails to raise the serum concentration over a 24-hour period.
Explanation: ***3% saline to increase sodium by 4-6 mEq/L in first 2-4 hours, then slower correction*** - For **acute symptomatic hyponatremia** (seizures, confusion) in **TURP syndrome**, a rapid initial rise of **4-6 mEq/L** is required to reverse cerebral edema and prevent herniation. - After the initial stabilization, the rate is slowed to stay within **6-8 mEq/L per 24 hours** to mitigate the risk of **Osmotic Demyelination Syndrome (ODS)**. *Conivaptan infusion for water diuresis* - **Vaptans** are Vasopressin receptor antagonists typically used for **euvolemic hyponatremia** (SIADH) rather than acute, life-threatening hyponatremia. - This treatment is too slow for a patient presenting with **seizures** and severe neurological compromise. *Normal saline infusion with fluid restriction* - **Normal saline (0.9%)** may worsen hyponatremia in high ADH states or be insufficient to rapidly increase sodium in a **hypervolemic** post-TURP state. - **Fluid restriction** alone is an appropriate long-term strategy for mild cases but is contraindicated as primary therapy for **acute, symptomatic seizures**. *Rapid correction to 135 mEq/L with 3% hypertonic saline over 4 hours* - Correcting sodium to **normal levels (135 mEq/L)** too quickly represents an overcorrection that carries an extremely high risk of **pontine myelinolysis**. - The goal of emergency treatment is **symptom reversal**, not immediate normalization of laboratory values. *Increase sodium by 6-8 mEq/L in first 24 hours with 3% saline boluses* - While 6-8 mEq/L is a safe 24-hour target, it does not prioritize the necessary **early rapid rise** needed in the first few hours for a patient having **seizures**. - This approach lacks the specific **2-4 hour urgency** required to manage active intracranial pressure increases from acute hypotonicity.
Explanation: ***Normal saline with potassium chloride*** - The patient has **hypochloremic, hypokalemic metabolic alkalosis** due to high-output gastric suctioning; a **urine chloride <10 mEq/L** confirms it is **chloride-responsive**. - Administering **Isotonic Saline (0.9% NaCl)** restores volume and provides the chloride needed to promote renal **bicarbonate excretion**, while **KCl** corrects the hypokalemia that maintains alkalosis. *Discontinue nasogastric suction only* - While suctioning is the source of acid loss, stopping it alone does not address the existing **volume depletion** or the severe **electrolyte imbalances** already present. - The kidneys require exogenous **chloride replacement** to effectively reverse the metabolic alkalosis and restore acid-base balance. *Acetazolamide to promote bicarbonate excretion* - This carbonic anhydrase inhibitor can lower bicarbonate but may worsen **hypokalemia** and contributes to further **volume depletion**. - It is generally reserved for patients with severe volume overload who cannot tolerate saline, which is not the case for this **hypovolemic** patient. *Half-normal saline with potassium supplementation* - **0.45% Saline** provides less sodium and chloride than required for rapid volume expansion and correction of **contraction alkalosis**. - **Isotonic 0.9% saline** is preferred to reliably expand the **extracellular fluid volume** and suppress the renin-angiotensin-aldosterone system. *Hydrochloric acid infusion* - This is an extreme measure reserved for life-threatening **metabolic alkalosis (pH >7.55-7.60)** that is refractory to standard saline and potassium replacement. - It requires **central venous access** due to its caustic nature and is not indicated as initial management for **chloride-responsive** states.
Explanation: ***Combined hyperkalemia and hypocalcemia*** - Massive transfusion protocols involve multiple blood products that synergistically cause **hyperkalemia** (due to potassium leakage from stored RBCs) and **hypocalcemia** (due to **citrate anticoagulants** binding ionized calcium). - These two derangements are most responsible for cardiac instability because **hypocalcemia** lowers the threshold for action potential while **hyperkalemia** increases membrane excitability, significantly increasing the risk of **fatal arrhythmias**. *Hypothermia-induced arrhythmia* - While massive transfusion can cause hypothermia if blood products aren't warmed, the primary markers here are **hyperkalemia** and **hypocalcemia**. - Hypothermia typically presents with **Osborn (J) waves** on EKG rather than the **peaked T waves** seen in this patient. *Hyperkalemia from massive transfusion* - Hyperkalemia alone explains the **peaked T waves** and elevated K+ of 6.8 mEq/L, but it ignores the significant **low ionized calcium (0.9 mmol/L)**. - Cardiac stabilization in this setting requires treating both electrolytes; addressing potassium without calcium is insufficient for **myocardial membrane stabilization**. *Hypocalcemia from citrate toxicity* - Citrate in FFP and PRBCs binds calcium, leading to the reported **ionized calcium** level, which can cause QT prolongation and reduced contractility. - This option is incomplete as it fails to account for the **life-threatening hyperkalemia** evidenced by the elevated serum potassium and EKG changes. *Metabolic acidosis alone* - The **pH of 7.25** indicates a metabolic acidosis which can shift K+ out of cells, but it is a contributing factor rather than the primary cause of instability in this 2-hour post-op window. - Acidosis primarily worsens the severity of **citrate toxicity** by decreasing the liver\'s ability to metabolize citrate, further exacerbating the hypocalcemia.
Explanation: ***Lactated Ringer's solution with potassium supplementation*** - **Lactated Ringer's (LR)** is the ideal crystalloid for volume resuscitation in this patient as the **lactate** is metabolized to bicarbonate, helping to correct her **hyperchloremic metabolic acidosis**. - Compared to Normal Saline, LR has a **lower sodium content** (130 mEq/L) which helps address the **hypernatremia**, while potassium supplementation is vital to treat the severe **hypokalemia** (2.8 mEq/L). *3% hypertonic saline* - This solution is used for treating severe **hyponatremia** or cerebral edema, whereas this patient is already **hypernatremic** (Na+ 148 mEq/L). - Administration would dangerously worsen the hyperosmolar state and aggravate **cellular dehydration**. *0.9% normal saline with 40 mEq/L potassium chloride* - **Normal Saline (0.9% NaCl)** contains 154 mEq/L of chloride, which can exacerbate the patient's existing **hyperchloremia** and metabolic acidosis. - It is less physiologic than LR in this scenario of **bicarbonate loss** typically seen in small bowel diarrhea. *0.45% normal saline with 20 mEq/L potassium chloride* - **0.45% NaCl (Half-normal saline)** is a hypotonic solution unsuitable for initial **resuscitation** in a patient with 6 kg of acute weight loss and signs of **prerenal azotemia**. - It lacks sufficient volume expansion capacity and does not provide an **alkalinizing agent** to treat the systemic acidosis correctly. *D5W with potassium phosphate* - **D5W** is essentially free water and is contraindicated as an initial resuscitation fluid in **hypovolemic shock** as it will not stay in the intravascular space. - While it provides water for hypernatremia, it fails to restore the **effective circulating volume** needed to correct the elevated **creatinine** and BUN.
Explanation: ***Mixed metabolic acidosis: high anion gap and normal anion gap*** - The patient has **metabolic acidosis** (pH 7.30, Low HCO3-) with an **anion gap** calculated as 138 - (112 + 18) = 8 mEq/L, which typically suggests a **normal anion gap metabolic acidosis (NAGMA)**. - However, the massive **Normal Saline** infusion (12L) causes **hyperchloremic acidosis**, while the clinical context of small bowel obstruction and potential **hypoperfusion** suggests an underlying **high anion gap metabolic acidosis (HAGMA)** that is being offset by the extreme chloride load, indicating a mixed process. *Metabolic alkalosis with paradoxical aciduria* - Gastric suctioning via **nasogastric tube** typically causes loss of H+ and Cl-, leading to **contraction alkalosis**, which is the opposite of this patient's acidic pH. - **Paradoxical aciduria** occurs in severe volume depletion where the kidney reabsorbs Na+ at the expense of H+ secretion, but this patient's labs show clear **acidosis**. *Metabolic acidosis with appropriate respiratory compensation* - While the low pH and low bicarbonate confirm **metabolic acidosis**, this option fails to address the specific etiology or the **mixed nature** of the anion gap. - Respiratory compensation is expected, but the primary clinical task is identifying the specific **physiologic mechanisms** (saline vs. ischemia) driving the pH change. *Normal anion gap metabolic acidosis from saline administration* - Large volumes of **0.9% Normal Saline** cause **hyperchloremic metabolic acidosis** because the chloride concentration (154 mEq/L) is higher than plasma levels. - While NAGMA is present, focusing only on this ignores the potential for **lactic acidosis** (HAGMA) given the clinical setting of **small bowel obstruction** and intensive resuscitation. *High anion gap metabolic acidosis from bowel ischemia* - Ischemia leads to **lactic acidosis**, which increases the **anion gap**; however, the calculated gap here is numerically normal (8 mEq/L). - This diagnosis cannot be made in isolation because the **hyperchloremia** from saline resuscitation has altered the electrolyte profile to look like a NAGMA.
Explanation: ***Magnesium sulfate 2 grams IV followed by calcium*** - In patients with a history of **alcoholism** and **acute pancreatitis**, hypocalcemia is frequently driven by concurrent **hypomagnesemia**. - Magnesium is a necessary cofactor for **PTH secretion** and end-organ responsiveness; failure to correct magnesium first will result in **refractory hypocalcemia**. *Oral calcium carbonate 1000 mg three times daily* - Oral supplementation is inappropriate for **acute, symptomatic hypocalcemia** (perioral numbness, carpopedal spasm) which requires immediate IV intervention. - Patients with acute pancreatitis often have **impaired absorption** and high metabolic demand, making the oral route insufficient. *Intravenous calcium gluconate 1-2 grams over 10 minutes* - While IV calcium gluconate is used for symptomatic hypocalcemia, it will be **ineffective** if the underlying **hypomagnesemia** is not addressed first. - Magnesium deficiency causes a functional **hypoparathyroidism**, preventing the body from maintaining calcium levels even after IV administration. *Intravenous calcium chloride bolus* - Calcium chloride is significantly more **caustic to peripheral veins** and is generally reserved for emergency situations like **cardiac arrest** or severe hyperkalemia. - Giving a bolus without addressing the **magnesium deficit** in an alcoholic patient fails to treat the root cause of the electrolyte disturbance. *Vitamin D supplementation only* - Vitamin D takes **days to weeks** to increase serum calcium levels via intestinal absorption and bone resorption, which is too slow for acute management. - It does not address the immediate life-threatening potential of **neuromuscular irritability** or the secondary effects of pancreatitis-related **saponification**.
Explanation: ***Syndrome of inappropriate ADH secretion (SIADH)*** - This patient demonstrates **hypotonic hyponatremia** with **high urine sodium (>40 mEq/L)** and inappropriately concentrated urine, which are the diagnostic hallmarks of **SIADH**. - Postoperative **pain, stress, and nausea** are potent triggers for ADH release, and the administration of **hypotonic fluids (D5W)** further worsens the water retention and hyponatremia. *Diuretic use* - Although diuretics can cause hyponatremia and high urine sodium, they usually lead to **hypovolemia** and elevated **blood urea nitrogen (BUN)** levels, which are not described here. - Thiazide diuretics are a more common cause of hyponatremia than loop diuretics, but there is no history of medication use in this patient. *Cerebral salt wasting* - This condition occurs primarily in patients with **central nervous system pathology** (e.g., subarachnoid hemorrhage) and results in massive **renal sodium wasting**. - It is distinguished from SIADH by the presence of true **hypovolemia** and clinical signs of dehydration, whereas SIADH patients are usually **euvolemic**. *Primary polydipsia* - In primary polydipsia, the excess intake of water leads to maximal suppression of ADH, resulting in **dilute urine** (osmolality <100 mOsm/kg). - This patient has a **high urine osmolality (520 mOsm/kg)**, which directly contradicts a diagnosis of primary polydipsia. *Adrenal insufficiency* - Acute adrenal insufficiency can cause hyponatremia due to lack of mineralocorticoids but is typically associated with **hyperkalemia** and **hypotension**. - The clinical context of recent surgery and the specific labs provided (euvolemic hyponatremia) more strongly favor **SIADH** over adrenal failure.
Explanation: ***Administer packed red blood cells*** - The patient exhibits **hemorrhagic shock** (Class III/IV) with significant blood loss and persistent **hypotension** and **tachycardia** despite initial crystalloid resuscitation. - **Packed red blood cells (PRBCs)** are essential to restore **oxygen-carrying capacity** and volume in patients who do not stabilize after early crystalloid infusion. *Give fresh frozen plasma only* - **Fresh frozen plasma (FFP)** is used to replace clotting factors and is typically given alongside PRBCs in a **massive transfusion protocol**. - Using FFP alone does not address the critical need for **hemoglobin** and oxygen delivery in acute traumatic hemorrhage. *Continue crystalloid resuscitation with normal saline* - Excessive **crystalloid administration** can lead to **hemodilution**, coagulopathy, and "the lethal triad" in trauma patients. - This patient has already received 3 liters of fluid; continuing with only crystalloids fails to address the **2-liter blood loss** effectively. *Give 5% albumin solution* - **Albumin** is a colloid that may be used for volume expansion but has no advantage over blood products in **acute trauma** management. - Colloid solutions like albumin do not provide the **erythrocytes** needed to treat the profound anemia associated with a 2-liter hemorrhage. *Administer hypertonic saline* - **Hypertonic saline** is primarily used to manage **intracranial pressure** in head trauma rather than as a primary resuscitation fluid for hemorrhagic shock. - It provides rapid but transient volume expansion and does not replace the **red cell mass** lost during surgery.
Body fluid compartments
Practice Questions
Assessment of volume status
Practice Questions
Crystalloid vs. colloid solutions
Practice Questions
Maintenance fluid requirements
Practice Questions
Replacement of ongoing losses
Practice Questions
Electrolyte disorders (Na, K, Ca, Mg)
Practice Questions
Acid-base disorders in surgical patients
Practice Questions
Goal-directed fluid therapy
Practice Questions
Fluid management in special populations
Practice Questions
Transfusion triggers and strategies
Practice Questions
Blood component therapy
Practice Questions
Massive transfusion protocols
Practice Questions
Point-of-care coagulation testing
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free